May 7, 2008 - Edward M. Bernstein & Associates, one of Nevada's leading Personal Injury Law Firms announces that on April 28, 2008, Actavis Totowa LLC in conjunction with the FDA announced a nationwide recall of Digitek, a drug used to treat heart failure and abnormal heart rhythms. This recall puts Las Vegas Heart Medicine patients at risk.
The products are distributed by Mylan Pharmaceuticals Inc., under a "Bertek" label and by UDL Laboratories, Inc. under a "UDL" label. The recall is in effect due to the possibility that some tablets may have double the thickness in size, posing a significant risk by potentially causing Digitalis toxicity. Digitalis toxicity can cause vomiting, nausea, dizziness, low blood pressure, cardiac instability and bradycardia - several reports of illness and injuries have already been reported.
"We believe this recall may represent a serious health problem to tens of thousands of patients throughout Nevada who may be taking Digitek," indicated Ed Bernstein, Managing Partner of Edward M. Bernstein and Associates. "Based on what we have learned to date, there has been an irregularity in manufacturing the product, causing some medication to be much larger in size and dosage than what was prescribed. The danger is particularly high for those patients with renal failure and we are urging any patient who may have been impacted by this recall with any symptoms; such as; dizziness, nausea, and low blood pressure. Affected people should contact us immediately so that we can assist them with the proper legal representation."
No comments:
Post a Comment